Wellington Shields Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Wellington Shields Capital Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,000	Closed	-$311K	–	321
2023 Q1	$311K	Hold	4,000	–	–	0.04%	189
2022 Q4	$311K	Hold	4,000	–	–	0.04%	189
2022 Q3	$269K	Buy	+4,000	New	+$295K	0.06%	195

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

Alerus Financial Grand Forks, North Dakota $2.29B AUM 30.87% 1-Year Est. Return

Wellington Shields Capital Management's PPH Position: Q2 2023 in Review

Wellington Shields Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 4,000 shares — an estimated $311K sold.

Wellington Shields Capital Management first reported a position in PPH in Q3 2022 and held it in 3 quarters. The position peaked at $311K in Q4 2022. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

Wellington Shields Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
Wellington Shields Capital Management sold 4,000 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $311K.
Wellington Shields Capital Management first reported a position in VanEck Pharmaceutical ETF in Q3 2022 and held it in 3 quarters.
Wellington Shields Capital Management's VanEck Pharmaceutical ETF position peaked at $311K in Q4 2022.
102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on Wellington Shields Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.